#1

Portfolio, M&A, and Commercial Strategy

Kardam supports portfolio and product‑selection strategy in pharmaceuticals, aligning API capabilities, CGMP capacity, and commercial priorities. The firm also provides business‑case development and diligence support for mergers and acquisitions, including asset and platform evaluations, and assists with business development and licensing, carve‑outs, and integration of generic and API assets into existing pharmaceutical manufacturing platforms.

#2 Operational Turnarounds and Efficiency

The firm advises on operational turnarounds where performance, compliance, and service levels are critical to value. Engagements include multi‑year efficiency programs, yield and cost‑of‑goods improvements, and stabilizing CGMP manufacturing and supply chain performance under sponsor or corporate ownership.

#3 API and Drug Product Manufacturing

Kardam helps evaluate and design API and finished‑dose manufacturing networks across international, multi‑site operations. Work typically addresses network rationalization, site carve‑outs, CGMP readiness, and capital allocation to improve manufacturing efficiency and resilience in generic and branded drugs and APIs.

#4 Investor and Board Advisory

Kardam serves private equity firms, lenders, and boards seeking an independent operating view on pharmaceutical, API, and CDMO/CMO platforms. Typical mandates include investment and investment‑committee (IC) support, board‑level operating reviews, leadership and organization design at the CEO/COO/CCO level, and ongoing advisory roles for sponsors and strategic acquirers.

#5 Sectors and Focus Areas

Pharmaceuticals, including oral solid, sterile, special delivery systems, and high‑potency products
Active pharmaceutical ingredients, excipients, and intermediates
Pharmaceutical supply chain and CGMP manufacturing networks
CEO, COO, and CCO‑level leadership transitions and operating model design in complex organizations

Operational Turnarounds in Pharmaceuticals

Transforming Underperforming Pharmaceutical Operations

In the pharmaceutical industry, operational inefficiencies can lead to increased costs, compliance risks, and missed opportunities. At Kardam Consulting, we specialize in stabilizing and improving underperforming operations, helping companies achieve measurable results and long-term success.

Our Approach to Operational Turnarounds

We take a hands-on approach to operational turnarounds, focusing on:

Pharmaceutical Operations Turnaround: Stabilizing operations to restore efficiency and reliability.
Pharma Manufacturing Efficiency: Implementing strategies to improve yield, reduce waste, and lower production costs.
CGMP Readiness: Ensuring compliance with regulatory standards to minimize risks and avoid disruptions.
Cost of Goods Reduction: Identifying and addressing inefficiencies to reduce production costs.

Why Choose Kardam Consulting?

With decades of experience in pharmaceutical manufacturing and operations, Kardam Consulting brings unparalleled expertise to every engagement. Our team combines deep industry knowledge with a hands-on approach to deliver customized solutions that drive meaningful improvements.

Case Study:

A pharmaceutical company faced declining performance and rising costs. Kardam Consulting conducted a comprehensive assessment of their operations, identifying key areas for improvement. By implementing targeted efficiency programs, we helped the company achieve a 20% reduction in production costs and a significant improvement in compliance metrics.

Take the First Step Toward Transformation

Ready to turn your operations around? Kardam Consulting is here to help.

Turn your operations around with Kardam's proven strategies—schedule a consultation.